speb/financial-data huggingface dataset:
Financial ratios for 7130.T — annual report dated 2023-03-31
Total revenue: 4414279279.27928
Gross profit: 511951951.951952
Operating income: 86929429.42942944
Net income: 61629129.129129134
Capital expenditures: 61366366.36636637
Operating cash flow: 103228228.22822824
Depreciation & amortization: 56674174.17417418
Net tangible assets: 308716216.21621627
Owner earnings: 56936936.936936945
Return on net tangible assets (%): 18.4431312468082
Capex to operating income (%): 70.5933154849296
Buffett classification: The Good
Stock price: 12.581156156156156
P/E ratio: 5.668193275034718
Shares outstanding: 27765796
Book value: 502582582.5825825
P/B ratio: 0.6950615229857794
Market cap (USD): 349325815.275976
Debt to equity: 0.7571402963671131
Current ratio: 0.9493468296729539
Quick ratio: 0.8036885898392002
Effective tax rate (%): 40.20828781589105
Interest coverage ratio: 53.11467889908258
COGS to revenue (%): 88.40219598559139
SG&A to revenue (%): 2.9227085182879744
Free cash flow (dilution-adjusted): 16599099.0990991
Buyback yield (%): 0
Retained earnings: 428723723.72372377
Inventory turnover: 29.902145774607373
Receivables turnover: 9.296158102766798
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.879962414846139
FCF margin (%): 0.3760319193444697
Revenue growth (%): 6.948555532808025
Rule of 40 score: 7.324587452152495
Financial ratios for 7130.T — annual report dated 2024-03-31
Total revenue: 4706266508.188062
Gross profit: 591224247.2266244
Operating income: 91944004.22609614
Net income: 62163232.96354992
Capital expenditures: 85307712.62546223
Operating cash flow: 158055995.77390385
Depreciation & amortization: 62744321.18330692
Net tangible assets: 297741679.8732171
Owner earnings: 39599841.52139461
Return on net tangible assets (%): 13.300066533599466
Capex to operating income (%): 92.7822464808963
Buffett classification: The Gruesome
Stock price: 17.49557580559958
P/E ratio: 7.814564422761845
Shares outstanding: 27765796
Book value: 622603011.0935025
P/B ratio: 0.7802380972549767
Market cap (USD): 485778588.7208136
Debt to equity: 1.2238696745044382
Current ratio: 1.0213568067440635
Quick ratio: 0.849348667357061
Effective tax rate (%): 40.14115851719972
Interest coverage ratio: 29.008333333333333
COGS to revenue (%): 87.43751026003306
SG&A to revenue (%): 3.163527739621758
Free cash flow (dilution-adjusted): 47609614.368726894
Buyback yield (%): 0
Retained earnings: 425105652.40359217
Inventory turnover: 16.45582255083179
Receivables turnover: 6.037876669970604
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.427044384111118
FCF margin (%): 1.0116217236294351
Revenue growth (%): 6.614607061211017
Rule of 40 score: 7.626228784840452
Financial ratios for 7130.T — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 296652192.18377924
Buffett classification: The Gruesome
Stock price: 13.468693094270906
Shares outstanding: 27765796
Book value: 618202829.527945
P/B ratio: 0.604929267515153
Market cap (USD): 373968984.8421347
Debt to equity: 1.4773131521406642
Current ratio: 0.9897124038877204
Quick ratio: 0.7934272072430893
Buyback yield (%): 0
Retained earnings: 468665079.1427371
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 7130.T — annual report dated 2025-03-31
Total revenue: 6729808849.084347
Gross profit: 840375618.2328565
Operating income: 105507285.12230985
Net income: 61121507.81981018
Capital expenditures: 146324020.85282716
Operating cash flow: 173319074.9899746
Depreciation & amortization: 84474000.80203182
Net tangible assets: 309403823.01831305
Owner earnings: -728512.2309851646
Return on net tangible assets (%): -0.23545676452163466
Capex to operating income (%): 138.68617762574434
Buffett classification: The Gruesome
Stock price: 15.532281780510626
P/E ratio: 7.055882335291416
Shares outstanding: 27765796
Book value: 612565165.0848818
P/B ratio: 0.7040331248225896
Market cap (USD): 431266167.33217484
Debt to equity: 1.3855453236154145
Current ratio: 0.9889114208051084
Quick ratio: 0.7745178409630236
Effective tax rate (%): 47.3520607874741
Interest coverage ratio: 15.645193260654112
COGS to revenue (%): 87.5126376234713
SG&A to revenue (%): 3.92128821329329
Free cash flow (dilution-adjusted): 5226573.987434835
Buyback yield (%): 10.922721381741274
Retained earnings: 476259858.30771285
Inventory turnover: 19.703875136960264
Receivables turnover: 10.713218708771333
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.275016119140103
FCF margin (%): 0.07766303775694847
Revenue growth (%): 42.99676478957755
Rule of 40 score: 43.074427827334496
Financial ratios for 7130.T — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 309403823.01831305
Buffett classification: The Gruesome
Stock price: 15.532281780510626
Shares outstanding: 27765796
Book value: 612565165.0848818
P/B ratio: 0.7040331248225896
Market cap (USD): 431266167.33217484
Debt to equity: 1.3855453236154145
Current ratio: 0.9889114208051084
Quick ratio: 0.7745178409630236
Buyback yield (%): 0
Retained earnings: 476259858.30771285
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 7130.T — quarterly report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 15.885067810683642
Shares outstanding: 27765796
Market cap (USD): 441061552.27760863
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 7593.T — annual report dated 2022-03-31
Total revenue: 1949926241.599738
Gross profit: 326921816.095722
Operating income: 83527290.60809703
Net income: 101802983.11752172
Capital expenditures: 57277495.49254221
Operating cash flow: 137829863.9567284
Depreciation & amortization: 78413374.8565809
Net tangible assets: 301106376.0039338
Owner earnings: 122938862.48156041
Return on net tangible assets (%): 40.82904656922784
Capex to operating income (%): 68.57339089481947
Buffett classification: The Good
Stock price: 3.0282740534338632
P/E ratio: 3.4581748105933023
Shares outstanding: 116255169
Book value: 466595640.0590067
P/B ratio: 0.7545130764954158
Market cap (USD): 352052511.86026883
Debt to equity: 0.8132398918045457
Current ratio: 0.8360313789507097
Quick ratio: 0.4104316872987802
Effective tax rate (%): 30.831338047775493
Interest coverage ratio: 13.961643835616437
COGS to revenue (%): 83.23414449628042
SG&A to revenue (%): 12.578909763375782
Free cash flow (dilution-adjusted): 64399278.806752995
Buyback yield (%): 0
Retained earnings: 355654810.68677264
Inventory turnover: 5.274991343259729
Receivables turnover: 12.081344571950847
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.208640083335837
FCF margin (%): 3.3026520405161177
Rule of 40 score: 3.3026520405161177
Financial ratios for 7593.T — annual report dated 2023-03-31
Total revenue: 1999466966.966967
Gross profit: 329632132.1321322
Operating income: 96516516.51651652
Net income: 70075075.07507508
Capital expenditures: 80480480.48048049
Operating cash flow: 83881381.38138139
Depreciation & amortization: 80067567.56756757
Net tangible assets: 374917417.41741747
Owner earnings: 69662162.16216215
Return on net tangible assets (%): 18.580668415466864
Capex to operating income (%): 83.38518979464841
Buffett classification: The Gruesome
Stock price: 3.303828828828829
P/E ratio: 5.481081232250911
Shares outstanding: 116255169
Book value: 546096096.0960963
P/B ratio: 0.7033325848478139
Market cap (USD): 384087178.84256756
Debt to equity: 0.8431811932911738
Current ratio: 0.8897007845283708
Quick ratio: 0.37696588213829596
Effective tax rate (%): 26.182191997469555
Interest coverage ratio: 14.845265588914549
COGS to revenue (%): 83.51399960199603
SG&A to revenue (%): 12.3629045278584
Free cash flow (dilution-adjusted): -19031531.53153153
Buyback yield (%): 0
Retained earnings: 421396396.39639646
Inventory turnover: 3.9572643490018864
Receivables turnover: 11.815314316135042
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.694261899612357
FCF margin (%): -0.9518302550604701
Revenue growth (%): 2.5406461183160216
Rule of 40 score: 1.5888158632555514
Financial ratios for 7593.T — annual report dated 2024-03-31
Total revenue: 2057606973.0586371
Gross profit: 327542260.96143687
Operating income: 79285525.62070787
Net income: 50310353.93555204
Capital expenditures: 66211040.676175386
Operating cash flow: 79661912.30850501
Depreciation & amortization: 81807976.75647122
Net tangible assets: 384343634.4426836
Owner earnings: 65907290.01584786
Return on net tangible assets (%): 17.148011339232024
Capex to operating income (%): 83.50961938868994
Buffett classification: The Gruesome
Stock price: 3.2072768092974115
P/E ratio: 7.411247950517128
Shares outstanding: 116255169
Book value: 541481774.9603803
P/B ratio: 0.6885965968511744
Market cap (USD): 372862507.4946514
Debt to equity: 0.8692592863588694
Current ratio: 0.9267288652514236
Quick ratio: 0.38360301077207376
Effective tax rate (%): 33.50497469017281
Interest coverage ratio: 8.408263305322128
COGS to revenue (%): 84.08139818487567
SG&A to revenue (%): 12.04445385810195
Free cash flow (dilution-adjusted): -12169836.238774432
Buyback yield (%): 0.9138194233424601
Retained earnings: 401281035.3935552
Inventory turnover: 3.623703355370529
Receivables turnover: 11.15021827810778
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.59109479754724
FCF margin (%): -0.5914558221332203
Revenue growth (%): 2.907775274720533
Rule of 40 score: 2.3163194525873125
Financial ratios for 7593.T — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 402486342.6250175
Buffett classification: The Gruesome
Stock price: 3.0644347947891863
Shares outstanding: 116255169
Book value: 567747583.6951954
P/B ratio: 0.6274907990607306
Market cap (USD): 356256384.95769715
Debt to equity: 0.9415763048493148
Current ratio: 0.933757104397248
Quick ratio: 0.39998504337421487
Buyback yield (%): 0
Retained earnings: 421704720.5490965
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 7593.T — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 379461301.9649779
Buffett classification: The Gruesome
Stock price: 3.1778505547386713
Shares outstanding: 116255169
Book value: 537408100.5213206
P/B ratio: 0.6874506598235229
Market cap (USD): 369441553.297888
Debt to equity: 0.8815650378698373
Current ratio: 0.9438231703206574
Quick ratio: 0.40582141760357143
Buyback yield (%): 0
Retained earnings: 395669028.20478547
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 7593.T — annual report dated 2025-03-31
Total revenue: 2350153722.764336
Gross profit: 356757118.03234863
Operating income: 72577195.56209062
Net income: 40910306.10880898
Capital expenditures: 71053335.11562625
Operating cash flow: 186846678.25157064
Depreciation & amortization: 100033417.99224703
Net tangible assets: 379461301.9649779
Owner earnings: 69890388.98542976
Return on net tangible assets (%): 18.418317921620435
Capex to operating income (%): 97.90035914909292
Buffett classification: The Gruesome
Stock price: 3.1778505547386713
P/E ratio: 9.030525274371836
Shares outstanding: 116255169
Book value: 537408100.5213206
P/B ratio: 0.6874506598235229
Market cap (USD): 369441553.297888
Debt to equity: 0.8815650378698373
Current ratio: 0.9438231703206574
Quick ratio: 0.40582141760357143
Effective tax rate (%): 37.10439786272092
Interest coverage ratio: 6.169886363636363
COGS to revenue (%): 84.81983903534966
SG&A to revenue (%): 12.027415180729745
Free cash flow (dilution-adjusted): 79274161.2083946
Buyback yield (%): 0.24965696949476984
Retained earnings: 395669028.20478547
Inventory turnover: 4.152366101883693
Receivables turnover: 11.134578847371754
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.520447667130678
FCF margin (%): 3.373147911156614
Revenue growth (%): 14.217814846866872
Rule of 40 score: 17.590962758023487
Financial ratios for 7593.T — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 381554508.74831766
Buffett classification: The Gruesome
Stock price: 3.2395693135935395
Shares outstanding: 116255169
Book value: 530269179.00403786
P/B ratio: 0.7102367871849538
Market cap (USD): 376616678.0390309
Debt to equity: 1.0321835579583236
Current ratio: 0.9433257275352045
Quick ratio: 0.4082245999571712
Buyback yield (%): 0
Retained earnings: 414313593.5397039
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9364.T — annual report dated 2022-03-31
Total revenue: 2144574659.8918211
Gross profit: 392919193.5748238
Operating income: 233764956.56449762
Net income: 170963776.43009344
Capital expenditures: 0
Operating cash flow: 303524012.45697427
Depreciation & amortization: 107211932.47008687
Net tangible assets: 2946164563.186363
Owner earnings: 278175708.90018034
Return on net tangible assets (%): 9.441960994851053
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 15.646451401409607
P/E ratio: 9.035958946342937
Shares outstanding: 98733037
Book value: 3015210621.209638
P/B ratio: 0.5123428705999739
Market cap (USD): 1544821665.1340766
Debt to equity: 0
Current ratio: 2.399776972400334
Quick ratio: 2.3833930218095256
Effective tax rate (%): 31.57373477270476
COGS to revenue (%): 81.67807368513571
Free cash flow (dilution-adjusted): 303524012.45697427
Buyback yield (%): 1.7506711210240908
Retained earnings: 2638321586.6251435
Inventory turnover: 279.75916230366494
Receivables turnover: 5.558810408921933
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.349595339381556
FCF margin (%): 14.153110084415758
Rule of 40 score: 14.153110084415758
Financial ratios for 9364.T — annual report dated 2023-03-31
Total revenue: 2058100600.6006007
Gross profit: 385525525.52552557
Operating income: 237094594.59459463
Net income: 184857357.35735738
Capital expenditures: 0
Operating cash flow: 266996996.99699703
Depreciation & amortization: 102019519.51951952
Net tangible assets: 2737672672.6726727
Owner earnings: 286876876.8768769
Return on net tangible assets (%): 10.478859643830658
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 18.725600600600604
P/E ratio: 10.001416461732934
Shares outstanding: 98733037
Book value: 2800330330.3303304
P/B ratio: 0.6602204736068514
Market cap (USD): 1848835416.9463217
Debt to equity: 0.05361872794929813
Current ratio: 3.090173868456626
Quick ratio: 3.071155549340418
Effective tax rate (%): 29.564048286515245
Interest coverage ratio: 1754.5
COGS to revenue (%): 81.2678969427918
Free cash flow (dilution-adjusted): 266996996.99699703
Buyback yield (%): 4.994622100806682
Retained earnings: 2356238738.738739
Inventory turnover: 273.02328431372547
Receivables turnover: 5.667424696615741
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.6442880241666105
FCF margin (%): 12.972980860074635
Revenue growth (%): -4.03222424047398
Rule of 40 score: 8.940756619600656
Financial ratios for 9364.T — annual report dated 2024-03-31
Total revenue: 1761654780.7712626
Gross profit: 336839672.4775489
Operating income: 202007395.66825145
Net income: 165312995.24564183
Capital expenditures: 0
Operating cash flow: 280447702.06022185
Depreciation & amortization: 90141310.08980455
Net tangible assets: 2501934759.640782
Owner earnings: 255454305.33544636
Return on net tangible assets (%): 10.210270445745895
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 20.541468568409933
P/E ratio: 12.268373537032156
Shares outstanding: 98733037
Book value: 2557389064.976228
P/B ratio: 0.7930438133073064
Market cap (USD): 2028121576.1991549
Debt to equity: 0.07746113387607768
Current ratio: 3.183063816535801
Quick ratio: 3.1632003914851974
Effective tax rate (%): 29.538705206889727
Interest coverage ratio: 711.4418604651163
COGS to revenue (%): 80.87898495042825
Free cash flow (dilution-adjusted): 280447702.06022185
Buyback yield (%): 3.809353494062743
Retained earnings: 2095582408.8748019
Inventory turnover: 241.62709966405376
Receivables turnover: 5.549580845797017
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.96913642120994
FCF margin (%): 15.919560694941618
Revenue growth (%): -14.403854687318415
Rule of 40 score: 1.5157060076232032
Financial ratios for 9364.T — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 2695349488.723911
Buffett classification: The Gruesome
Stock price: 21.434514637904467
Shares outstanding: 98733037
Book value: 2752941588.457767
P/B ratio: 0.7687394224760281
Market cap (USD): 2116294726.8212633
Debt to equity: 0.07632325442356863
Current ratio: 3.410928672316384
Quick ratio: 3.3907574152542375
Buyback yield (%): 0
Retained earnings: 2276362235.607228
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9364.T — annual report dated 2025-03-31
Total revenue: 1865940382.3018312
Gross profit: 371180323.4861649
Operating income: 221200374.28151315
Net income: 180316802.5665018
Capital expenditures: 0
Operating cash flow: 270077529.7420131
Depreciation & amortization: 88163347.14610346
Net tangible assets: 2514403154.6584682
Owner earnings: 268480149.71260524
Return on net tangible assets (%): 10.67768902593001
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 22.42300494586285
P/E ratio: 12.277787457741576
Shares outstanding: 98733037
Book value: 2569963908.568373
P/B ratio: 0.8614484310810157
Market cap (USD): 2213891376.97106
Debt to equity: 0.10529025949370381
Current ratio: 3.351093013287613
Quick ratio: 3.328675525075011
Effective tax rate (%): 29.156601197353215
Interest coverage ratio: 418.9367088607595
COGS to revenue (%): 80.1076000601758
Free cash flow (dilution-adjusted): 270077529.7420131
Buyback yield (%): 5.132192790566751
Retained earnings: 2118760860.8474803
Inventory turnover: 213.81070745697895
Receivables turnover: 5.754906002638522
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.446808510638298
FCF margin (%): 14.474070677909035
Revenue growth (%): 5.919752420784268
Rule of 40 score: 20.393823098693304
Financial ratios for 9364.T — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 2514403154.6584682
Buffett classification: The Gruesome
Stock price: 22.42300494586285
Shares outstanding: 98733037
Book value: 2569963908.568373
P/B ratio: 0.8614484310810157
Market cap (USD): 2213891376.97106
Debt to equity: 0.10529025949370381
Current ratio: 3.351093013287613
Quick ratio: 3.328675525075011
Buyback yield (%): 0
Retained earnings: 2118760860.8474803
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9364.T — quarterly report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 26.622681981732633
Shares outstanding: 98733037
Market cap (USD): 2628538245.1416416
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9364.T — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 2601884253.028264
Buffett classification: The Gruesome
Stock price: 29.602422611036342
Shares outstanding: 98733037
Book value: 2658499327.0524898
P/B ratio: 1.0993935778744626
Market cap (USD): 2922737086.945088
Debt to equity: 0.10279633365649674
Current ratio: 2.6912683137593776
Quick ratio: 2.669684590910876
Buyback yield (%): 0
Retained earnings: 2181372812.9205923
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9968.HK — annual report dated 2021-12-31
Capital expenditures: 1798273.1554160125
Buffett classification: The Gruesome
Stock price: 0.24615384615384614
Shares outstanding: 5254000000
Market cap (USD): 1293292307.6923077
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9968.HK — annual report dated 2022-12-31
Total revenue: 12340948.27586207
Gross profit: 996551.724137931
Operating income: -49214224.137931034
Net income: -352398563.2183908
Capital expenditures: 900000
Operating cash flow: -337219109.1954023
Depreciation & amortization: 2336206.896551724
Net tangible assets: 104539511.49425288
Owner earnings: -350962356.3218391
Return on net tangible assets (%): -335.72220809653726
Buffett classification: The Gruesome
Stock price: 0.011553273427471117
Shares outstanding: 5254000000
Book value: 189464224.1379311
P/B ratio: 0.3203818497350857
Market cap (USD): 60700898.58793325
Debt to equity: 3.5378892839836458
Current ratio: 1.0105218536257279
Quick ratio: 0.39366898985027904
Interest coverage ratio: -1.7204227085290085
COGS to revenue (%): 91.92483671544828
SG&A to revenue (%): 406.86319024833216
Free cash flow (dilution-adjusted): -339261781.6091954
Buyback yield (%): 0
Retained earnings: -50618103.448275864
Inventory turnover: 0.014993035834831078
Receivables turnover: 4.10382226469183
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.317625284195854
FCF margin (%): -2749.0738476942242
Rule of 40 score: -2749.0738476942242
Financial ratios for 9968.HK — annual report dated 2023-12-31
Total revenue: 132379606.18846694
Gross profit: 36345428.97327707
Operating income: -3076511.9549929677
Net income: -97991561.1814346
Capital expenditures: 38537.27144866385
Operating cash flow: 1790436.005625879
Depreciation & amortization: 2044585.0914205343
Net tangible assets: 1167791.8424753868
Owner earnings: -95985513.36146273
Return on net tangible assets (%): -8219.402625557028
Buffett classification: The Gruesome
Stock price: 0.006402048655569783
Shares outstanding: 5254000000
Book value: 73898593.5302391
P/B ratio: 0.4551691991620887
Market cap (USD): 33636363.63636364
Debt to equity: 9.415247640454568
Current ratio: 0.686203317017487
Quick ratio: 0.21931605943010893
Interest coverage ratio: -0.12260592234696681
COGS to revenue (%): 72.54454064356968
SG&A to revenue (%): 29.779466840342156
Free cash flow (dilution-adjusted): 1246132.2081575245
Buyback yield (%): 0
Retained earnings: -147258790.43600562
Inventory turnover: 0.14905511522250328
Receivables turnover: 97.34398593442961
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.611478008189143
FCF margin (%): 0.9413324635393038
Revenue growth (%): 972.6858522484135
Rule of 40 score: 973.6271847119529
Financial ratios for 9968.HK — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -116548082.19178082
Buffett classification: The Gruesome
Stock price: 0.001288659793814433
Shares outstanding: 5254000000
Book value: -45818493.15068483
Market cap (USD): 6770618.556701031
Debt to equity: -15.507957246431006
Current ratio: 0.6240035508177213
Quick ratio: 0.1882689293568959
Buyback yield (%): 0
Retained earnings: -252943698.630137
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9968.HK — annual report dated 2024-12-31
Total revenue: 33002054.79452055
Gross profit: 8581369.8630137
Operating income: -5147123.287671233
Net income: -109517671.23287672
Capital expenditures: 48630.13698630137
Operating cash flow: -23295479.452054795
Depreciation & amortization: 1403287.6712328768
Net tangible assets: -116548082.19178082
Owner earnings: -108163013.69863014
Buffett classification: The Gruesome
Stock price: 0.001288659793814433
Shares outstanding: 5254000000
Book value: -45818493.15068483
Market cap (USD): 6770618.556701031
Debt to equity: -15.507957246431006
Current ratio: 0.6240035508177213
Quick ratio: 0.1882689293568959
Interest coverage ratio: -0.08513771944930346
COGS to revenue (%): 73.99746798663429
SG&A to revenue (%): 41.59890417782206
Free cash flow (dilution-adjusted): -23349726.02739726
Buyback yield (%): 0
Retained earnings: -252943698.630137
Inventory turnover: 0.03924619202677365
Receivables turnover: 18.009643417806686
Capitalized R&D asset: 0
FCF margin (%): -70.75234003694248
Revenue growth (%): -75.07013674936002
Rule of 40 score: -145.8224767863025
Financial ratios for ABBV — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 114.88
Shares outstanding: 1766792821
Market cap (USD): 202969159276.47998
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ABBV — annual report dated 2022-12-31
Total revenue: 58054000000
Gross profit: 40640000000
Operating income: 18814000000
Net income: 11845000000
Capital expenditures: 695000000
Operating cash flow: 24943000000
Depreciation & amortization: 8467000000
Net tangible assets: -82341000000
Owner earnings: 19617000000
Return on net tangible assets (%): -23.82409735125879
Capex to operating income (%): 3.6940576166684385
Buffett classification: The Great
Stock price: 142.46
P/E ratio: 21.249244852651753
Shares outstanding: 1766792821
Book value: 17287000000
P/B ratio: 14.559918162761614
Market cap (USD): 251697305279.66
Debt to equity: 3.6600335512234627
Current ratio: 0.9636062021802424
Quick ratio: 0.8424402464621843
Effective tax rate (%): 12.109519922831492
Interest coverage ratio: 8.43677130044843
COGS to revenue (%): 29.99621042477693
R&D to revenue (%): 11.2136975918972
SG&A to revenue (%): 26.285871774554725
Free cash flow (dilution-adjusted): 23577000000
Buyback yield (%): 0.5907890028253578
Retained earnings: 4784000000
Inventory turnover: 4.865604917574742
Receivables turnover: 5.158521414608139
Capitalized R&D asset: 6510000000
ROCI (R&D-adjusted, %): 19.99879077882481
FCF margin (%): 40.61218865194474
Rule of 40 score: 40.61218865194474
Financial ratios for ABBV — annual report dated 2023-12-31
Total revenue: 54318000000
Gross profit: 33903000000
Operating income: 13535000000
Net income: 4873000000
Capital expenditures: 777000000
Operating cash flow: 22839000000
Depreciation & amortization: 8698000000
Net tangible assets: -77543000000
Owner earnings: 12794000000
Return on net tangible assets (%): -16.499232683801246
Capex to operating income (%): 5.74067233099372
Buffett classification: The Great
Stock price: 142.12
P/E ratio: 51.52813374112867
Shares outstanding: 1766792821
Book value: 10397000000
P/B ratio: 24.150870031789943
Market cap (USD): 251096595720.52002
Debt to equity: 5.711743772241993
Current ratio: 0.8721228297349436
Quick ratio: 0.7638011680452419
Effective tax rate (%): 22.032
Interest coverage ratio: 6.085881294964029
COGS to revenue (%): 37.58422622335137
R&D to revenue (%): 14.12975440921978
SG&A to revenue (%): 23.69748517986671
Free cash flow (dilution-adjusted): 21315000000
Buyback yield (%): 0.7853551316939837
Retained earnings: -1000000000
Inventory turnover: 4.980483044645036
Receivables turnover: 4.869385925593904
Capitalized R&D asset: 12036700000
ROCI (R&D-adjusted, %): 15.133749040845668
Rosenberg metric: -1.034869431643625
FCF margin (%): 39.24113553518171
Revenue growth (%): -6.4353877424466885
Rule of 40 score: 32.805747792735026
Financial ratios for ABBV — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 186.24
Shares outstanding: 1766792821
Market cap (USD): 329047494983.04004
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ABBV — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 168.92
Shares outstanding: 1766792821
Market cap (USD): 298446643323.32
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ABBV — annual report dated 2024-12-31
Total revenue: 56334000000
Gross profit: 39430000000
Operating income: 11894000000
Net income: 4286000000
Capital expenditures: 974000000
Operating cash flow: 18806000000
Depreciation & amortization: 8386000000
Net tangible assets: -91699000000
Owner earnings: 11698000000
Return on net tangible assets (%): -12.756954819572734
Capex to operating income (%): 8.18900285858416
Buffett classification: The Great
Stock price: 168.92
P/E ratio: 69.63290791491366
Shares outstanding: 1766792821
Book value: 3364000000
P/B ratio: 88.71778933511295
Market cap (USD): 298446643323.32
Debt to equity: 19.959571938168846
Current ratio: 0.6601976825208392
Quick ratio: 0.5522981238225503
Effective tax rate (%): -15.33907427341227
Interest coverage ratio: 4.235754985754986
COGS to revenue (%): 30.006745482301984
R&D to revenue (%): 22.705648453864452
SG&A to revenue (%): 26.186672347072815
Free cash flow (dilution-adjusted): 16921000000
Buyback yield (%): 0.5722966024950901
Retained earnings: -7900000000
Inventory turnover: 4.043051901458981
Receivables turnover: 5.159263668834142
Capitalized R&D asset: 20081550000
ROCI (R&D-adjusted, %): 13.471132092721014
Rosenberg metric: 0.7201302931596091
FCF margin (%): 30.036922639968754
Revenue growth (%): 3.711476858499945
Rule of 40 score: 33.7483994984687
Financial ratios for ABBV — quarterly report dated 2025-03-31
Total revenue: 13343000000
Gross profit: 9341000000
Operating income: 3981000000
Net income: 1289000000
Capital expenditures: 235000000
Operating cash flow: 1635000000
Depreciation & amortization: 2039000000
Net tangible assets: -92354000000
Owner earnings: 3093000000
Return on net tangible assets (%): -3.3490698832752233
Capex to operating income (%): 5.903039437327305
Buffett classification: The Great
Stock price: 201.05
P/E ratio: 68.89326932933476
Shares outstanding: 1766792821
Book value: 1462000000
P/B ratio: 242.96422480304378
Market cap (USD): 355213696662.05005
Debt to equity: 47.803693570451436
Current ratio: 0.7602395406971952
Quick ratio: 0.6359091283685411
Effective tax rate (%): 22.39614689945816
Interest coverage ratio: 5.687142857142857
COGS to revenue (%): 29.9932548902046
R&D to revenue (%): 15.491268830098178
SG&A to revenue (%): 24.67960728471858
Free cash flow (dilution-adjusted): 990000000
Buyback yield (%): 0.2705413696123025
Retained earnings: -9527000000
Inventory turnover: 0.8842244807777286
Receivables turnover: 1.0694077101867436
Capitalized R&D asset: 2067000000
ROCI (R&D-adjusted, %): 5.262744404835558
FCF margin (%): 7.41962077493817
Rule of 40 score: 7.41962077493817
Financial ratios for ABBV — quarterly report dated 2025-06-30
Total revenue: 15423000000
Gross profit: 11077000000
Operating income: 5717000000
Net income: 941000000
Capital expenditures: 269000000
Operating cash flow: 5153000000
Depreciation & amortization: 2050000000
Net tangible assets: -92852000000
Owner earnings: 2722000000
Return on net tangible assets (%): -2.931546977986473
Capex to operating income (%): 4.705264999125416
Buffett classification: The Great
Stock price: 179.76
P/E ratio: 142.42093161567712
Shares outstanding: 1766792821
Book value: -138000000
Market cap (USD): 317598677502.95996
Debt to equity: -510.731884057971
Current ratio: 0.7358110996554933
Quick ratio: 0.6110845676063067
Effective tax rate (%): 39.44658944658945
Interest coverage ratio: 7.725675675675675
COGS to revenue (%): 28.1786941580756
R&D to revenue (%): 13.817026518835505
SG&A to revenue (%): 21.091875769953965
Free cash flow (dilution-adjusted): 4705000000
Buyback yield (%): 0.00377835326467572
Retained earnings: -11503000000
Inventory turnover: 0.8762096774193548
Receivables turnover: 1.2204637176545066
Capitalized R&D asset: 3515890000
ROCI (R&D-adjusted, %): 6.38919033277787
Rosenberg metric: 0.8398645379777455
FCF margin (%): 30.50638656551903
Revenue growth (%): 15.588698193809488
Rule of 40 score: 46.095084759328515
Financial ratios for ABBV — quarterly report dated 2025-09-30
Total revenue: 15776000000
Gross profit: 10472000000
Operating income: 4584000000
Net income: 188000000
Capital expenditures: 381000000
Operating cash flow: 7024000000
Depreciation & amortization: 2063000000
Net tangible assets: -92583000000
Owner earnings: 1870000000
Return on net tangible assets (%): -2.019809252238532
Capex to operating income (%): 8.311518324607329
Buffett classification: The Great
Stock price: 226.17
P/E ratio: 165.25869823224565
Shares outstanding: 1766792821
Book value: -2599000000
Market cap (USD): 399595532325.57
Debt to equity: -26.44978838014621
Current ratio: 0.7245055977253687
Quick ratio: 0.5991470132771445
Effective tax rate (%): 73.66946778711485
Interest coverage ratio: 6.20297699594046
COGS to revenue (%): 33.62068965517241
R&D to revenue (%): 14.699543610547666
SG&A to revenue (%): 22.622971602434077
Free cash flow (dilution-adjusted): 6434000000
Buyback yield (%): 0.0010010121926841277
Retained earnings: -14234000000
Inventory turnover: 1.0741190765492101
Receivables turnover: 1.2354922076905004
Capitalized R&D asset: 4428880000
ROCI (R&D-adjusted, %): 4.781548076053567
Rosenberg metric: -0.28390427029563586
FCF margin (%): 40.78346855983773
Revenue growth (%): 2.2887894702716722
Rule of 40 score: 43.0722580301094
Financial ratios for ABBV — quarterly report dated 2025-12-31
Total revenue: 16618000000
Gross profit: 12066000000
Operating income: 5809000000
Net income: 1816000000
Capital expenditures: 329000000
Operating cash flow: 5218000000
Depreciation & amortization: 1987000000
Net tangible assets: -91551000000
Owner earnings: 3474000000
Return on net tangible assets (%): -3.7946062850214637
Capex to operating income (%): 5.663625408848339
Buffett classification: The Great
Stock price: 224.8
P/E ratio: 93.80609970732169
Shares outstanding: 1766792821
Book value: -3228000000
Market cap (USD): 397175026160.80005
Debt to equity: -20.909541511771994
Current ratio: 0.6713483794959458
Quick ratio: 0.5569775231583081
Effective tax rate (%): 31.971514242878563
Interest coverage ratio: 8.135854341736694
COGS to revenue (%): 27.391984595017448
R&D to revenue (%): 15.519316403899385
SG&A to revenue (%): 23.438440245516908
Free cash flow (dilution-adjusted): 4732000000
Buyback yield (%): 0.000755334500509461
Retained earnings: -15493000000
Inventory turnover: 0.9194102201575439
Receivables turnover: 1.320041305901978
Capitalized R&D asset: 4835960000
ROCI (R&D-adjusted, %): 6.329381649253625
Rosenberg metric: 0.6873652436394998
FCF margin (%): 28.47514743049705
Revenue growth (%): 5.3372210953346855
Rule of 40 score: 33.81236852583174
Financial ratios for ABBV — annual report dated 2025-12-31
Total revenue: 61160000000
Gross profit: 42956000000
Operating income: 20091000000
Net income: 4233000000
Capital expenditures: 1214000000
Operating cash flow: 19030000000
Depreciation & amortization: 8139000000
Net tangible assets: -91551000000
Owner earnings: 11158000000
Return on net tangible assets (%): -12.187742351257768
Capex to operating income (%): 6.042506594992783
Buffett classification: The Great
Stock price: 224.8
P/E ratio: 93.82826037344672
Shares outstanding: 1766792821
Book value: -3228000000
Market cap (USD): 397175026160.80005
Debt to equity: -20.909541511771994
Current ratio: 0.6713483794959458
Quick ratio: 0.5569775231583081
Effective tax rate (%): 35.83447021373352
Interest coverage ratio: 6.944694089180781
COGS to revenue (%): 29.764551994767825
R&D to revenue (%): 14.872465663832571
SG&A to revenue (%): 22.907128842380644
Free cash flow (dilution-adjusted): 16861000000
Buyback yield (%): 0.24674260349975724
Retained earnings: -15493000000
Inventory turnover: 3.67683296303777
Receivables turnover: 4.858209548018111
Capitalized R&D asset: 20198720000
ROCI (R&D-adjusted, %): 17.437583498903038
Rosenberg metric: 0.2756625752482214
FCF margin (%): 27.568672334859386
Revenue growth (%): 8.566762523520431
Rule of 40 score: 36.13543485837982
Financial ratios for ALGTR.PA — annual report dated 2021-12-31
Total revenue: 13345454.545454545
Gross profit: 6646590.909090909
Operating income: 76136.36363636363
Net income: 179545.45454545456
Capital expenditures: 9090.90909090909
Operating cash flow: -1967045.4545454546
Depreciation & amortization: 1013636.3636363636
Net tangible assets: -906818.1818181818
Owner earnings: 1184090.909090909
Return on net tangible assets (%): -130.5764411027569
Capex to operating income (%): 11.940298507462686
Buffett classification: The Great
Stock price: 5.3181818181818175
P/E ratio: 60.10977189873416
Shares outstanding: 2029347
Book value: 2201136.3636363633
P/B ratio: 4.903120268456376
Market cap (USD): 10792436.318181816
Debt to equity: 3.2457408363448637
Current ratio: 1.9952559794425775
Quick ratio: 1.8248665744218222
Interest coverage ratio: 0.25769230769230766
COGS to revenue (%): 50.195844686648506
Free cash flow (dilution-adjusted): -3171590.909090909
Buyback yield (%): 0
Retained earnings: -4831818.181818182
Inventory turnover: 6.838747099767981
Receivables turnover: 2.8763164339946115
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.6766993233006766
FCF margin (%): -23.765326975476842
Rule of 40 score: -23.765326975476842
Financial ratios for ALGTR.PA — annual report dated 2022-12-31
Total revenue: 14986170.212765958
Gross profit: 7575531.914893618
Operating income: -484042.55319148937
Net income: -184042.55319148937
Capital expenditures: 302127.6595744681
Operating cash flow: -9574.468085106384
Depreciation & amortization: 989361.7021276596
Net tangible assets: -1702127.6595744682
Owner earnings: 503191.48936170206
Buffett classification: The Gruesome
Stock price: 7.074468085106384
Shares outstanding: 2029347
Book value: 2108510.6382978708
P/B ratio: 6.808858501513629
Market cap (USD): 14356550.585106384
Debt to equity: 3.9843592330978836
Current ratio: 1.9059206744587087
Quick ratio: 1.726384364820847
Interest coverage ratio: -1.8421052631578947
COGS to revenue (%): 49.44984737701427
Free cash flow (dilution-adjusted): -9574.468085106384
Buyback yield (%): 0.8373373899588152
Retained earnings: -4476595.744680852
Inventory turnover: 7.434364994663821
Receivables turnover: 4.109393232205368
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.260299625468165
FCF margin (%): -0.06388869170156883
Revenue growth (%): 12.294190967592334
Rule of 40 score: 12.230302275890764
Financial ratios for ALGTR.PA — annual report dated 2023-12-31
Total revenue: 14280000
Gross profit: 6416666.666666666
Operating income: -1192222.2222222222
Net income: -2090000
Capital expenditures: 0
Operating cash flow: -705555.5555555555
Depreciation & amortization: 1065555.5555555555
Net tangible assets: -2930000
Owner earnings: -1024444.4444444445
Buffett classification: The Gruesome
Stock price: 4.222222222222222
Shares outstanding: 2029347
Book value: 2158888.88888889
P/B ratio: 3.9688721564590823
Market cap (USD): 8568354
Debt to equity: 5.125064333504887
Current ratio: 2.39574172645221
Quick ratio: 2.160610969682944
Interest coverage ratio: -2.4497716894977173
COGS to revenue (%): 55.065359477124176
Free cash flow (dilution-adjusted): -705555.5555555555
Buyback yield (%): 0
Inventory turnover: 6.965551181102363
Receivables turnover: 4.132475884244373
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.494300189993668
FCF margin (%): -4.940865234982882
Revenue growth (%): -4.712145950166826
Rule of 40 score: -9.653011185149708
Financial ratios for ALGTR.PA — annual report dated 2024-12-31
Total revenue: 13418750
Gross profit: 7005208.333333334
Operating income: -520833.3333333334
Net income: -736458.3333333334
Capital expenditures: 0
Operating cash flow: 2360416.666666667
Depreciation & amortization: 2076041.6666666667
Net tangible assets: -3407291.666666667
Owner earnings: 1339583.3333333335
Buffett classification: The Gruesome
Stock price: 1.9791666666666667
Shares outstanding: 2029347
Book value: 1283333.333333332
P/B ratio: 3.1296747564935097
Market cap (USD): 4016415.9375
Debt to equity: 6.531655844155851
Current ratio: 1.5118723238614247
Quick ratio: 1.3154924094978588
Interest coverage ratio: -1.1086474501108647
COGS to revenue (%): 47.795373389225276
Free cash flow (dilution-adjusted): 2360416.666666667
Buyback yield (%): 0
Retained earnings: -736458.3333333334
Inventory turnover: 6.102081268582755
Receivables turnover: 4.298298298298298
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.124525981346726
FCF margin (%): 17.5904362676603
Revenue growth (%): -6.031162464985995
Rule of 40 score: 11.559273802674307
Financial ratios for ALGTR.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -3407291.666666667
Buffett classification: The Gruesome
Stock price: 1.9791666666666667
Shares outstanding: 2029347
Book value: 1283333.333333332
P/B ratio: 3.1296747564935097
Market cap (USD): 4016415.9375
Debt to equity: 6.531655844155851
Current ratio: 1.5118723238614247
Quick ratio: 1.3154924094978588
Buyback yield (%): 0
Retained earnings: -736458.3333333334
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALGTR.PA — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: -1805882.3529411766
Buffett classification: The Gruesome
Stock price: 6.705882352941177
Shares outstanding: 2029347
Book value: 2610588.2352941167
P/B ratio: 5.212833663812531
Market cap (USD): 13608562.235294119
Debt to equity: 3.4646237043713395
Current ratio: 1.0920296960358595
Quick ratio: 0.9481720128869591
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALPRG.PA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.3863636363636364
Shares outstanding: 100549117
Market cap (USD): 38848522.477272734
Buyback yield (%): 3.659317828425964
Retained earnings: -1012500
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALPRG.PA — annual report dated 2022-12-31
Total revenue: 115311702.12765957
Gross profit: 32061702.127659578
Operating income: 2177659.574468085
Net income: 1394680.8510638298
Capital expenditures: 3159574.4680851065
Operating cash flow: 3654255.3191489363
Depreciation & amortization: 3572340.425531915
Net tangible assets: -1946808.510638298
Owner earnings: 1807446.8085106388
Return on net tangible assets (%): -92.84153005464482
Capex to operating income (%): 145.0903761602345
Buffett classification: The Gruesome
Stock price: 0.23404255319148937
P/E ratio: 16.87323092295957
Shares outstanding: 100549117
Book value: 33087234.0425532
P/B ratio: 0.7112341887981479
Market cap (USD): 23532772.063829787
Debt to equity: 0.5432448074078836
Current ratio: 2.9790257488773944
Quick ratio: 2.9650997555846073
Effective tax rate (%): -54.44839857651246
Interest coverage ratio: 3.411666666666666
COGS to revenue (%): 72.19562148847251
SG&A to revenue (%): 1.9733746644155985
Free cash flow (dilution-adjusted): -994680.8510638298
Buyback yield (%): 0
Retained earnings: 660638.2978723404
Inventory turnover: 319.4081632653061
Receivables turnover: 4.145364846259752
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.985836603118573
FCF margin (%): -0.8626018285313628
Rule of 40 score: -0.8626018285313628
Financial ratios for ALPRG.PA — annual report dated 2023-12-31
Total revenue: 124110000
Gross profit: 35355555.55555555
Operating income: -1190000
Net income: -11181111.11111111
Capital expenditures: 2566666.6666666665
Operating cash flow: 7136666.666666666
Depreciation & amortization: 9397777.777777778
Net tangible assets: -8040000
Owner earnings: -4349999.999999998
Buffett classification: The Gruesome
Stock price: 0.24444444444444444
Shares outstanding: 100549117
Book value: 23907777.777777776
P/B ratio: 1.0280617995073662
Market cap (USD): 24578673.04444444
Debt to equity: 0.7435980852349305
Current ratio: 2.607835654773262
Quick ratio: 2.5925077911340075
Interest coverage ratio: -1.4433962264150944
COGS to revenue (%): 71.51272616585645
SG&A to revenue (%): 1.809326851628036
Free cash flow (dilution-adjusted): 4214444.444444444
Buyback yield (%): 0
Inventory turnover: 331.44813278008303
Receivables turnover: 6.75571549534293
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.9877874496557102
FCF margin (%): 3.3957331757670164
Revenue growth (%): 7.630013008220088
Rule of 40 score: 11.025746183987104
Financial ratios for ALPRG.PA — annual report dated 2024-12-31
Total revenue: 115920833.33333334
Gross profit: 33997916.66666667
Operating income: 5158333.333333334
Net income: 2943750
Capital expenditures: 2143750
Operating cash flow: 6350000
Depreciation & amortization: 2304166.666666667
Net tangible assets: -7009375
Owner earnings: 3104166.666666667
Return on net tangible assets (%): -44.285926586417006
Capex to operating income (%): 41.5589660743134
Buffett classification: The Good
Stock price: 0.20833333333333334
P/E ratio: 7.116002618542109
Shares outstanding: 100549117
Book value: 24888541.666666664
P/B ratio: 0.8416617168208262
Market cap (USD): 20947732.708333336
Debt to equity: 0.5732222826769348
Current ratio: 2.764694041867955
Quick ratio: 2.75174449812131
Effective tax rate (%): 16.35238656452563
Interest coverage ratio: 8.308724832214766
COGS to revenue (%): 70.67143524675605
SG&A to revenue (%): 1.8502210560368069
Free cash flow (dilution-adjusted): 3473958.3333333335
Buyback yield (%): 0
Inventory turnover: 407.4922279792746
Receivables turnover: 6.774869109947644
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.129288571797284
FCF margin (%): 2.9968369217497575
Revenue growth (%): -6.598313324201641
Rule of 40 score: -3.6014764024518833
Financial ratios for ALPRG.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -7009375
Buffett classification: The Gruesome
Stock price: 0.20833333333333334
Shares outstanding: 100549117
Market cap (USD): 20947732.708333336
Quick ratio: -0.012949543746645198
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALPRG.PA — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 16143529.411764706
Buffett classification: The Gruesome
Stock price: 0.29411764705882354
Shares outstanding: 100549117
Book value: 26920000.000000004
P/B ratio: 1.0985612817935495
Market cap (USD): 29573269.705882356
Debt to equity: 0.15846516912857267
Current ratio: 3.1477916800342207
Quick ratio: 3.1326061383809214
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMANTA.NS — quarterly report dated 2025-09-30
Total revenue: 7991803.833145434
Gross profit: 5357474.633596392
Operating income: 1125986.4712514093
Net income: 136133.03269447575
Capital expenditures: 0
Depreciation & amortization: 525704.6223224351
Net tangible assets: 23660225.47914318
Owner earnings: 661837.6550169109
Return on net tangible assets (%): 2.7972584437131847
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.537316798196167
P/E ratio: 109.62257354782611
Shares outstanding: 38829351
Book value: 23751984.21645998
P/B ratio: 2.5131800784032285
Market cap (USD): 59693013.55535514
Debt to equity: 0.8821972269806213
Current ratio: 2.031993091982231
Quick ratio: 1.3377774691184994
Effective tax rate (%): 46.988322065150584
Interest coverage ratio: 1.9387180681729947
COGS to revenue (%): 32.96288615873365
Buyback yield (%): 0
Inventory turnover: 0.2816326776588564
Receivables turnover: 1.5023556664215276
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.7080912207139765
Revenue growth (%): -5.135673345018448
Rule of 40 score: -5.135673345018448
Financial ratios for AMANTA.NS — quarterly report dated 2025-12-31
Total revenue: 8297582.711373511
Gross profit: 5369199.064275371
Operating income: 1190531.3579146708
Net income: 515639.96880917903
Capital expenditures: 0
Depreciation & amortization: 520697.3376406372
Owner earnings: 1036337.3064498162
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.2148824774423528
P/E ratio: 25.533517285900118
Shares outstanding: 38829351
Market cap (USD): 47173098.1403587
Effective tax rate (%): 26.567358334919728
Interest coverage ratio: 2.1118005058488776
COGS to revenue (%): 35.292009118320685
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 3.8261559544277195
Rule of 40 score: 3.8261559544277195
Financial ratios for AMCO.L — annual report dated 2024-12-31
Total revenue: 72582500
Gross profit: 26453750
Operating income: 6063750
Net income: 1310000
Capital expenditures: 1608750
Operating cash flow: 8506250
Depreciation & amortization: 2451250
Net tangible assets: 4063750
Owner earnings: 2152500
Return on net tangible assets (%): 52.96831744078745
Capex to operating income (%): 26.53061224489796
Buffett classification: The Good
Stock price: 0.0072499999999999995
P/E ratio: 0.3983565740458015
Shares outstanding: 71978912
Book value: 25516250
P/B ratio: 0.020451559770734335
Market cap (USD): 521847.11199999996
Debt to equity: 0.9940724048400529
Current ratio: 1.5180139720558883
Quick ratio: 1.1798902195608783
Effective tax rate (%): 37.97014925373134
Interest coverage ratio: 2.2070063694267517
COGS to revenue (%): 63.55354252058003
SG&A to revenue (%): 28.21616780904488
Free cash flow (dilution-adjusted): 6802500
Buyback yield (%): 0
Retained earnings: 3861250
Inventory turnover: 5.446133412042503
Receivables turnover: 6.400573192239859
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.411728584587044
FCF margin (%): 9.372093824268935
Revenue growth (%): 21.883675204591345
Rule of 40 score: 31.25576902886028